These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26176646)

  • 21. Coordinated Technology-Delivered Treatment to Prevent Rehospitalization in Schizophrenia: A Novel Model of Care.
    Brunette MF; Rotondi AJ; Ben-Zeev D; Gottlieb JD; Mueser KT; Robinson DG; Achtyes ED; Gingerich S; Marcy P; Schooler NR; Meyer-Kalos P; Kane JM
    Psychiatr Serv; 2016 Apr; 67(4):444-7. PubMed ID: 26725297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial.
    Fortney JC; Pyne JM; Kimbrell TA; Hudson TJ; Robinson DE; Schneider R; Moore WM; Custer PJ; Grubbs KM; Schnurr PP
    JAMA Psychiatry; 2015 Jan; 72(1):58-67. PubMed ID: 25409287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study.
    Weiden PJ; Manning R; Wolfgang CD; Ryan JM; Mancione L; Han G; Ahmed S; Mayo MG
    CNS Drugs; 2016 Aug; 30(8):735-47. PubMed ID: 27379654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy.
    Lipkovich I; Deberdt W; Csernansky JG; Buckley P; Peuskens J; Kollack-Walker S; Zhang Y; Liu-Seifert H; Houston JP
    J Psychiatr Res; 2007; 41(3-4):305-10. PubMed ID: 17010994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of smartphone-based ambulatory assessment (SBAA-BD) including a predicting system for upcoming episodes in the long-term treatment of patients with bipolar disorders: study protocol for a randomized controlled single-blind trial.
    Mühlbauer E; Bauer M; Ebner-Priemer U; Ritter P; Hill H; Beier F; Kleindienst N; Severus E
    BMC Psychiatry; 2018 Oct; 18(1):349. PubMed ID: 30367608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study.
    Stewart S; Chan YK; Wong C; Jennings G; Scuffham P; Esterman A; Carrington M;
    Eur J Heart Fail; 2015 Jun; 17(6):620-30. PubMed ID: 25899895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tecla: a telephone- and text-message based telemedical concept for patients with severe mental health disorders--study protocol for a controlled, randomized, study.
    Stentzel U; Grabe HJ; Strobel L; Penndorf P; Langosch J; Freyberger HJ; Hoffmann W; van den Berg N
    BMC Psychiatry; 2015 Nov; 15():273. PubMed ID: 26537570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention.
    Nicholl D; Nasrallah H; Nuamah I; Akhras K; Gagnon DD; Gopal S
    Curr Med Res Opin; 2010 Jun; 26(6):1471-84. PubMed ID: 20402565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis.
    Kam SM; Singh SP; Upthegrove R
    Early Interv Psychiatry; 2015 Aug; 9(4):279-83. PubMed ID: 24251970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability of Texting 4 Relapse Prevention, Text Messaging-Based Relapse Prevention Program for People With Schizophrenia and Schizoaffective Disorder.
    Ybarra ML; Rodriguez KM; Fehmie DA; Mojtabai R; Cullen B
    J Nerv Ment Dis; 2022 Feb; 210(2):123-128. PubMed ID: 34570061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Lann HD; Breier AF; Summerfelt AT
    Am J Psychiatry; 1999 Mar; 156(3):412-8. PubMed ID: 10080557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
    Nakonezny PA; Byerly MJ
    Schizophr Res; 2006 Feb; 82(1):107-14. PubMed ID: 16376522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
    Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
    Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.
    Morken G; Widen JH; Grawe RW
    BMC Psychiatry; 2008 Apr; 8():32. PubMed ID: 18447935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse in schizophrenia: Definitively not a bolt from the blue.
    Spaniel F; Bakstein E; Anyz J; Hlinka J; Sieger T; Hrdlicka J; Görnerová N; Höschl C
    Neurosci Lett; 2018 Mar; 669():68-74. PubMed ID: 27109788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.
    Cullen BA; Rodriguez K; Eaton WW; Mojtabai R; Von Mach T; Ybarra ML
    Psychiatry Res; 2020 Oct; 292():113346. PubMed ID: 32750572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.